Kedrion Activates Nationwide Distribution Network for QIVIGY® in the U.S. [Yahoo! Finance]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Yahoo! Finance
FORT LEE, N.J. March 6, 2026 /PRNewswire/ -- Today Kedrion Biopharma announced the nationwide commercial availability of QIVIGY, its FDA-approved 10% Intravenous Immunoglobulin (IVIG) therapy, through a broad U.S. distribution model designed to serve healthcare customers across specialty pharmacies, infusion centers, hospitals, and other sites of care. The launch is supported by key distribution partners and aligned group purchasing organization (GPO) relationships, providing the commercial infrastructure needed to support consistent supply, efficient ordering, and scalable access across the IVIG market. Kedrion launched their new logo on April 14, 2025. (PRNewsfoto/Kedrion Biopharma) Approved by the U.S. Food and Drug Administration in late 2025, QIVIGY is Kedrion's first fully proprietary IVIG, developed, manufactured, and released through the company's integrated global network, reinforcing long-term product consistency, quality, and supply reliability. QIVIGY is being intro
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Is Cencora Stock Outperforming the S&P 500? [Yahoo! Finance]Yahoo! Finance
- Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved Stem Cell Therapy into Veterinary Clinics [Yahoo! Finance]Yahoo! Finance
- Healthcare Logistics Industry Report 2026-2035: A $213.74 Billion Market by 2030 with AmerisourceBergen, CEVA Logistics, Cold Chain Technologies, Deutsche Post DHL Group, and UPS Healthcare Leading [Yahoo! Finance]Yahoo! Finance
- Bio-Pharmaceutical Logistics Market Report 2026-2035: A $259.32 Billion Market by 2030 with Kuehne + Nagel, FedEx, AmerisourceBergen, UPS, Kerry Logistics, and DB Schenker Leading [Yahoo! Finance]Yahoo! Finance
- Cencora's animal health unit to merge with Covetrus in $3.5 billion deal [Yahoo! Finance Canada]Yahoo! Finance Canada
COR
Earnings
- 2/4/26 - Beat
COR
Sec Filings
- 3/6/26 - Form 8-K
- 2/24/26 - Form 4
- 2/20/26 - Form 4
- COR's page on the SEC website